Alpha Tau Medical Ltd. (DRTS) Institutional Ownership

Ownership Summary

Alpha Tau Medical Ltd. (NASDAQ:DRTS) has 34 institutional investors with active 13F positions as of December 2025.

• They owned 2.8% of outstanding stock in December 2025, up from 2.3% the prior quarter.
• Their total shares held in DRTS increased 33.85% quarter over quarter, and separately, investors owning Alpha Tau Medical increased 54.55% from a year ago.
• Of these 34 funds, 13 grew their exposure to Alpha Tau Medical, 8 cut back, and 13 maintained positions.
• The aggregate institutional position in Alpha Tau Medical amounted to 2.27Mn shares as of December 2025, up by 573.38K shares quarter on quarter, and up 1.18Mn shares year over year.
• HighTower Advisors, LLC leads ownership in DRTS with 686.55K shares as of December 31, 2025, equal to 0.85% of outstanding shares.
• The largest buyers of Alpha Tau Medical for the quarter ending December 2025 were Apella Capital, LLC (382.28K), Daytona Street Capital LLC (151.23K), MILLENNIUM MANAGEMENT LLC (70.08K), Focus Partners Wealth (32.26K), Quent Capital, LLC (20.0K).
• The largest sellers of Alpha Tau Medical for the quarter ending December 2025 were Kovitz Investment Group Partners, LLC (45.37K), Morgan Stanley (30.9K), LEVIN CAPITAL STRATEGIES, L.P. (22.48K), UBS Group AG (9.92K), Summit Financial, LLC (7.56K).
• Per Business Quant data, the top 10 holders of Alpha Tau Medical for the quarter ending December 2025 are HighTower Advisors, LLC (686.55K), Apella Capital, LLC (382.28K), LEVIN CAPITAL STRATEGIES, L.P. (182.23K), Kovitz Investment Group Partners, LLC (157.86K), Daytona Street Capital LLC (151.23K), Mariner, LLC (125.16K), MILLENNIUM MANAGEMENT LLC (107.82K), SATOVSKY ASSET MANAGEMENT LLC (53.61K), Private Advisor Group, LLC (47.58K), Bank Of America Corp /De/ (44.14K).